Delirium: Symptoms, Causes, and Evidence-Based Management

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education

Delirium is a sudden, fluctuating disturbance in attention and awareness that develops over hours to days — not the gradual change of dementia, but an acute shift often triggered by illness, surgery, medication, or dehydration. It is common in hospitalized and older adults, frequently under-recognized, and usually reversible when the underlying cause is found and addressed. Understanding its signs and drivers helps families and patients respond quickly.

Recognizing the Symptoms

The hallmark of delirium is a rapid change in mental status that comes and goes across the day. Core features include reduced ability to focus or sustain attention, disorganized thinking, and altered consciousness — from drowsy and withdrawn (hypoactive) to restless and agitated (hyperactive). People may experience confusion about time or place, memory lapses, disrupted sleep-wake cycles, and sometimes hallucinations.

The hypoactive form is easy to miss because a quiet, sleepy patient does not draw attention. That is precisely why structured screening in hospitals matters.

What Causes Delirium

Delirium is almost always multifactorial. Common triggers include infection (urinary tract infections and pneumonia are frequent culprits), dehydration and electrolyte imbalance, certain medications and drug interactions, uncontrolled pain, low oxygen, alcohol or sedative withdrawal, and the physiological stress of major surgery. A vulnerable brain — older age, pre-existing cognitive impairment, sensory deficits — needs a smaller trigger to tip into delirium.

Because several factors usually stack together, effective evaluation is a systematic search for every contributing cause rather than a hunt for one.

The Genetic Susceptibility Angle

Delirium is driven mainly by acute triggers, but genetics appears to influence who is most vulnerable. The most studied variant is APOE ε4. Several studies have associated the APOE ε4 allele — already known for its role in brain aging — with higher risk and longer duration of delirium, particularly after surgery, although findings are not fully consistent across all populations.

Researchers have also examined genes affecting neurotransmitter signaling, such as COMT, which shapes dopamine breakdown in the brain and may influence cognitive resilience under stress. These are pathway-level tendencies that help explain differing vulnerability — they are not diagnostic and do not predict whether any individual will develop delirium.

Assessment and Evidence-Based Management

Management begins with recognition, often using validated tools like the Confusion Assessment Method, followed by a thorough search for reversible causes: reviewing medications, treating infection, correcting dehydration and electrolytes, managing pain, and restoring oxygenation. The most effective interventions are non-drug and preventive.

Evidence supports reorientation, early mobilization, restoring hearing aids and glasses, promoting normal sleep-wake cycles, hydration, and family presence. Medications are reserved for severe agitation or safety concerns and used sparingly under clinical supervision. This is general educational information — any specific care must come from the treating provider.

Where Genetic Pathway Insight Fits

No genetic test diagnoses, predicts, or prevents delirium, and PlexusDx makes no such claim. What pathway-level insight can offer is context about brain-related biological tendencies — for example, variants in APOE and COMT that influence neural stress-response pathways. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across systems that intersect with cognitive and metabolic health, giving you information to discuss proactively with your provider.

The framing is simple: PlexusDx tells you about your biology. It does not tell you what to put in your body, and it is not a substitute for clinical assessment of an acute condition like delirium.

Frequently Asked Questions

How is delirium different from dementia?

Delirium develops suddenly over hours to days and fluctuates, with attention the core deficit; it is usually reversible once the cause is treated. Dementia develops gradually over months to years and is progressive. The two can coexist — dementia raises delirium risk — which makes careful clinical assessment important.

Does the APOE ε4 variant cause delirium?

No. APOE ε4 is associated with somewhat higher delirium risk and duration in some studies, especially after surgery, but it does not cause delirium and findings are not fully consistent. Delirium requires an acute trigger such as infection or medication. The variant is a pathway-level tendency, not a diagnosis.

Can delirium be prevented?

Risk can often be reduced. Evidence-based, non-drug strategies — reorientation, early mobility, hydration, sleep support, restoring glasses and hearing aids, and careful medication review — lower delirium rates in vulnerable patients. Prevention is a clinical effort led by the care team, not something a genetic test performs.

Can genetic testing predict my risk of delirium?

No. Delirium is driven primarily by acute medical triggers, so it cannot be predicted genetically. Pathway-level insight describes tendencies in brain-related pathways such as those involving APOE and COMT. It offers context for proactive conversations with your provider — not a diagnosis or a risk forecast.

Curious about the genetic pathways behind your own biology? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights to give you pathway-level context you can bring to your provider — because with PlexusDx, you know your biology instead of guessing about it.

This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.